Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine/naloxone dosing in perioperative pain management
NCT03266445Phase 4Unknown
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of buprenorphine + naloxone in opioid use disorder (OUD), acute pain, sponsored by Massachusetts General Hospital. Status: unknown.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)acute pain
Beyond the preview
Go deeper on NCT03266445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03266445.